Zhongchao Inc. Announces 1-for-8 Share Consolidation
MWN-AI** Summary
Zhongchao Inc. (NASDAQ: ZCMD), an internet technology company focused on providing services for cancer patients and other major diseases, has announced a 1-for-8 share consolidation of its ordinary shares, set to take effect on March 2, 2026. This strategic move aims to help the Company regain compliance with Nasdaq Marketplace Rule 5550(a)(2) and ensure continued listing on the Nasdaq Capital Market.
Under this consolidation, every eight Class A ordinary shares, currently valued at US$0.001 each, will be consolidated into one new Class A ordinary share with a par value of US$0.008. Similarly, Class B ordinary shares will follow the same ratio. The consolidation will affect all shareholders uniformly, meaning their percentage interest in the Company’s total shares will remain unchanged, aside from adjustments from rounding of fractional shares.
As per the latest filings, Zhongchao currently has 25,754,124 Class A shares and 4,999,772 Class B shares outstanding, which post-consolidation will shrink to approximately 3,219,267 Class A shares and 624,972 Class B shares. Importantly, the consolidation has received prior approval from both the Company’s board of directors and its shareholders.
Zhongchao operates through its principal entity, Zhongchao Medical Technology (Shanghai) Limited, providing healthcare information, professional training, and patient management services, primarily through its comprehensive platforms, including "MDMOOC" and Zhongxin.
While the consolidation is a positive step toward compliance with listing requirements, the Company also cautions investors regarding forward-looking statements and associated risks inherent in their business and market operations. For more information, stakeholders are encouraged to visit their investor relations website.
MWN-AI** Analysis
Zhongchao Inc. (NASDAQ: ZCMD) has recently announced a 1-for-8 share consolidation aimed at regaining compliance with Nasdaq listing standards. This strategic move to consolidate shares—from 25.7 million Class A and roughly 5 million Class B shares to approximately 3.2 million Class A and 625,000 Class B shares—will enhance the share price and improve perceptions among investors.
**Market Implications:**
1. **Increased Share Price Stability**: Following the consolidation, the company’s share price should increase nominally, reflecting its new structure. A higher share price can help attract institutional investors who may be deterred by low-priced stocks.
2. **Compliance and Confidence**: The consolidation is a step towards maintaining Nasdaq listings, which can enhance investor confidence. A stable exchange listing can signal financial health and operational legitimacy, potentially leading to increased trading volume.
3. **Investor Sentiment**: Share consolidations often provide a mixed message. While it may be viewed positively as an effort to comply with market standards, investors should be cautious of potential underlying weaknesses that necessitated such a move. Regular monitoring of Zhongchao’s business performance post-consolidation will be essential to assess whether this action truly translates into long-term value creation.
4. **Market Positioning**: The company operates in the growing sectors of online healthcare and patient management. Any improvements in its service offerings, as well as successful expansion into more markets, should be scrutinized post-consolidation. The forward-looking statements made by the company indicate ambition; however, investors must weigh these against operational risks and competition.
**Conclusion**: Investors should wait for the post-consolidation trading window and assess market reactions and Zhongchao's performance closely. Strong service performance in the healthcare technology space could make ZCMD a compelling investment, provided it maintains compliance and demonstrates robust growth prospects.
**MWN-AI Summary and Analysis is based on asking OpenAI to summarize and analyze this news release.
PR Newswire
SHANGHAI, Feb. 26, 2026 /PRNewswire/ -- Zhongchao Inc. (NASDAQ: ZCMD) ("Zhongchao" or the "Company"), a platform-based internet technology company offering services for patients with cancer and other major diseases, today announced that the Company will effectuate a 1-for-8 share consolidation of the Company's ordinary shares of US$0.001 par value each (the "Share Consolidation").
Beginning with the opening of trading on March 2, 2026, the Company's Class A ordinary shares will begin trading on a post-Share Consolidation basis on the Nasdaq Capital Market under the same symbol "ZCMD", but under a new CUSIP number of G9897X123. The objective of the Share Consolidation is to enable the Company to regain compliance with Nasdaq Marketplace Rule 5550(a)(2) and maintain its listing on the Nasdaq Capital Market.
Upon the effectiveness of the Share Consolidation, every eight (8) Class A ordinary shares with a par value of US$0.001 each will be consolidated into one (1) Class A ordinary share with a par value of US$0.008 each, and every eight (8) Class B ordinary shares with a par value of US$0.001 each will be consolidated into one (1) Class B ordinary share with a par value of US$0.008 each. No fractional shares will be issued as a result of the Share Consolidation. Instead, any fractional shares that would have resulted from the Share Consolidation will be rounded up to the next whole number. Immediately prior to the Share Consolidation, the Company has a total of 25,754,124 Class A ordinary shares and 4,999,772 Class B ordinary shares issued and outstanding, respectively. As a result of the Share Consolidation, the Company will have approximately 3,219,267 Class A ordinary shares and 624,972 Class B ordinary shares issued and outstanding, respectively, subject to the rounding up of any fractional shares. The Share Consolidation affects all shareholders uniformly and will not alter any shareholder's percentage interest in the Company's outstanding ordinary shares, except for adjustments that may result from the treatment of fractional shares. The Share Consolidation was approved by the Company's shareholders and board of directors on February 10, 2026.
About Zhongchao Inc.
Zhongchao Inc. is an offshore holding company incorporated in the Cayman Islands. It consolidates the financial results of a variable interest entity, Zhongchao Medical Technology (Shanghai) Limited, and its subsidiaries (the "PRC operating entities") through a series of contractual arrangements. Zhongchao Inc. is a platform-based internet technology company offering services to patients with oncology and other major diseases. The PRC operating entities provide online healthcare information, professional training and educational services to healthcare professionals under their "MDMOOC" platform (www.mdmooc.org), offer patient management services in the professional field of tumor and rare diseases through Zhongxin, offer internet healthcare services through Zhixun Internet Hospital and operate an online information platform, Sunshine Health Forums, to general public. More information about the Company can be found at its investor relations website at http://izcmd.com.
Safe Harbor Statement
This press release contains forward-looking statements as defined by the Private Securities Litigation Reform Act of 1995. Forward-looking statements include statements concerning plans, objectives, goals, strategies, future events or performance, and underlying assumptions and other statements that are other than statements of historical facts. When the Company uses words such as "may," "will," "intend," "should," "believe," "expect," "anticipate," "project," "estimate" or similar expressions that do not relate solely to historical matters, it is making forward-looking statements. Forward-looking statements are not guarantees of future performance and involve risks and uncertainties that may cause the actual results to differ materially from the Company's expectations discussed in the forward-looking statements. These statements are subject to uncertainties and risks including, but not limited to, the following: the Company's goals and strategies; the Company's future business development; product and service demand and acceptance; changes in technology; economic conditions; the growth of the professional training and educational services market in China and the other international markets the Company plans to serve; reputation and brand; the impact of competition and pricing; government regulations; fluctuations in general economic and business conditions in China and the international markets the Company plans to serve and assumptions underlying or related to any of the foregoing and other risks contained in reports filed by the Company with the SEC. For these reasons, among others, investors are cautioned not to place undue reliance upon any forward-looking statements in this press release. Additional factors are discussed in the Company's filings with the SEC, which are available for review at www.sec.gov. The Company undertakes no obligation to publicly revise these forward–looking statements to reflect events or circumstances that arise after the date hereof.
For more information, please contact:
At the Company: Pei Xu, CFO
Email: xupei@mdmooc.org
Phone: +86 13901629242
Investor Relations: Sherry Zheng
WAVECREST GROUP INC.
Phone: +1 718-213-7386
Email: sherry@wavecrestipo.com
SOURCE Zhongchao Inc.
FAQ**
How will the 1-for-8 share consolidation impact the trading liquidity and market perception of Zhongchao Inc - Class A ZCMD shares on the Nasdaq Capital Market?
What specific steps will Zhongchao Inc - Class A ZCMD take post-consolidation to ensure continued compliance with Nasdaq Marketplace Rule 5550(a)(2)?
What are the long-term strategic goals for Zhongchao Inc - Class A ZCMD following the share consolidation, especially regarding its healthcare services expansion?
How does Zhongchao Inc - Class A ZCMD plan to address potential investor concerns about share consolidation and its implications for shareholder value in the coming quarters?
**MWN-AI FAQ is based on asking OpenAI questions about Zhongchao Inc - Class A (NASDAQ: ZCMD).
NASDAQ: ZCMD
ZCMD Trading
-1.23% G/L:
$1.65 Last:
21,808 Volume:
$1.61 Open:
